Informação sobre produto
- 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride, (2S)-
- 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride, (S)-
- Al 1577A
- Betaxon
- Levobetaxolol hydrochloride
- (2S)-1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(propan-2-ylamino)propan-2-ol hydrochloride (1:1)
The levorotatory enantiomer of betaxolol, levobetaxolol hydrochloride (LBX), is a beta-adrenergic receptor blocking agent that has been approved for use in pediatric patients and adults. It is currently being investigated as a treatment for cancer and other diseases. Levobetaxolol inhibits the proliferation and migration of cancer cells by inhibiting the activation of the beta-adrenergic receptors located on the surface of these cells. The drug also prevents the proliferation of hematopoietic cells and downregulates insulin resistance. LBX has been shown to have a protective effect on site-specific tissue, such as dental cavity sites, by preventing bacterial colonization.
Propriedades químicas
Consulta técnica sobre: 3D-REA20955 Levobetaxolol HCl
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
